Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 19:10:652.
doi: 10.3389/fneur.2019.00652. eCollection 2019.

Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications

Affiliations
Review

Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications

Nattakarn Limphaibool et al. Front Neurol. .

Abstract

Extensive research in recent decades has expanded our insights into the pathogenesis of Parkinson's disease (PD), though the underlying cause remains incompletely understood. Neuroinflammation have become a point of interest in the interconnecting areas of neurodegeneration and infectious diseases. The hypothesis concerning an infectious origin in PD stems from the observation of Parkinson-like symptoms in individuals infected with the influenza virus who then developed encephalitis lethargica. The implications of infectious pathogens have later been studied in neuronal pathways leading to the development of Parkinsonism and PD, through both a direct association and through synergistic effects of infectious pathogens in inducing neuroinflammation. This review explores the relationship between important infectious pathogens and Parkinsonism, including symptoms of Parkinsonism following infectious etiologies, infectious contributions to neuroinflammation and neurodegenerative processes associated with Parkinsonism, and the epidemiologic correlations between infectious pathogens and idiopathic PD.

Keywords: Parkinson's disease; encephalitis lethargica; infectious diseases; neurodegeneration; neuroinflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Infectious pathogens inciting the neuroinflammatory process and subsequent blood-brain barrier disturbance through the release of pro-inflammatory cytokines. This ultimately leads to the activation of microglia and subsequent clustering around neuronal cells, resulting in neuronal damage.
Figure 2
Figure 2
A diagram depicting the relationships between the different factors affecting neuroinflammation and neuronal cell death.

References

    1. Tysnes OB, Storstein A. Epidemiology of parkinson's disease. J Neural Transm (Vienna). (2017) 124:901–5. 10.1007/s00702-017-1686-y - DOI - PubMed
    1. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. (2007) 68:384–6. 10.1212/01.wnl.0000247740.47667.03 - DOI - PubMed
    1. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of parkinson's disease: a review of the evidence. Eur J Epidemiol. (2011) 26(Suppl. 1):S1–58. 10.1007/s10654-011-9581-6 - DOI - PubMed
    1. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, et al. Genome-wide association study reveals genetic risk underlying parkinson's disease. Nat Genet. (2009) 41:1308–12. 10.1038/ng.487 - DOI - PMC - PubMed
    1. International Parkinson Disease. Genomics C, Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, et al. Imputation of sequence variants for identification of genetic risks for parkinson's disease: a meta-analysis of genome-wide association studies. Lancet. (2011) 377:641–9. 10.1016/S0140-6736(10)62345-8 - DOI - PMC - PubMed

LinkOut - more resources